1 July 2014
Deltex Medical Group plc
("Deltex Medical" or "the Company")
Additional Listing
Deltex Medical Group plc was notified on 27 June 2014 that an employee has acquired 221,907 ordinary shares of 1p each, as the result of the exercise of options under the Company's 2003 and 2013 Enterprise Management Incentive Schemes.
Accordingly, application has been made for these shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 4 July 2014.
Following this, the total number of voting rights in issue will be 212,579,496.
For further information, please contact:-
Deltex Medical Group plc |
01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman |
|
Ewan Phillips, Chief Executive |
|
Paul Mitchell, Finance Director |
|
|
|
Nominated Adviser & Broker |
|
Arden Partners plc |
020 7614 5900 |
Chris Hardie |
|
Joint Broker Zeus Capital Limited Dominic Wilson John Goold
|
020 7533 7727
|
Financial Public Relations |
|
Newgate Threadneedle |
020 7653 9850 |
Caroline Forde |
|
Heather Armstrong |
|